Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

NCT07474142 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07474142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2026
Completion date
March 3, 2036
Enrollment
1,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed, treatment-naïve prostate cancer